Menu

Sign In

Sign In Create Free Account

My APIC My Courses

APIC Connect/IP Talk APIC Text AJIC Journal Prevention Strategist Staffing Calculator PolicyPro

Join APIC Today Explore Membership

Join

Membership

Membership Benefits and More

Explore the benefits of APIC Memnership, including access to resources and communities for infection preventionists.

Become a Member

Join an ever growing community of IPs today.

Education

Explore the Education Catalog

Courses, intensives, webinars and micro lessons.

Long-term Care CE Credit Only Outpatient Clinics and Surgery Centers Instructor-led Self-paced Webinars

Resources & Research

Explore the Resource Library

Playbooks, guides, toolkits, reports, white papers, issue briefs and more.

Implementation Guides C. Diff Professional Practice Toolkits

Career Development

Career Development

Find resources to help you take the next steps in your IP career.

New to Your IP Career?

Check out the Infection Preventionist Onboarding Checklist.

Go to the Checklist

Public Policy

Public Policy

APIC Government Affairs staff works with our Public Policy Committee to ensure that legislators and regulators have the best information to help carry out our mission.

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now

About

About Us

APIC is the leading professional association for infection preventionists. Explore to learn more.

Partner With Us

Build infection safe communities today.

Back to Policy Updates

FDA Issues EUA for Novavax COVID-19 Vaccine

Post Date: 07/22/2022

FDA Issues EUA for Novavax COVID-19 Vaccine

7/13/22 — The FDA issued emergency use authorization for the Novavax COVID-19 vaccine, adjuvanted for prevention of COVID-19 in individuals 18 years of age and older. Novavax is administered as a primary series in two doses, three weeks apart. Read more.